Kapp M - Search Results

1

Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.

Lutz M, Kapp M, Einsele H, Grigoleit GU, Mielke S. Lutz M, et al. Among authors: kapp m. Clin Transplant. 2014 Dec;28(12):1410-5. doi: 10.1111/ctr.12472. Epub 2014 Nov 3. Clin Transplant. 2014. PMID: 25287756 Clinical Trial.

2

High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.

Hefner J, Kapp M, Drebinger K, Dannenmann A, Einsele H, Grigoleit GU, Faller H, Csef H, Mielke S. Hefner J, et al. Among authors: kapp m. Bone Marrow Transplant. 2014 Apr;49(4):581-4. doi: 10.1038/bmt.2013.228. Epub 2014 Jan 20. Bone Marrow Transplant. 2014. PMID: 24442247

3

Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis.

Mielke S, Lutz M, Schmidhuber J, Kapp M, Ditz D, Ammer J, Einsele H, Grigoleit GU, Holler E, Wolff D. Mielke S, et al. Among authors: kapp m. Bone Marrow Transplant. 2014 Nov;49(11):1412-8. doi: 10.1038/bmt.2014.170. Epub 2014 Aug 4. Bone Marrow Transplant. 2014. PMID: 25089598

4

EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.

Rasche L, Kapp M, Einsele H, Mielke S. Rasche L, et al. Among authors: kapp m. Bone Marrow Transplant. 2014 Feb;49(2):163-7. doi: 10.1038/bmt.2013.96. Epub 2013 Jul 8. Bone Marrow Transplant. 2014. PMID: 23832092 Review.

5

Immunotherapy for viral and fungal infections.

Einsele H, Löffler J, Kapp M, Rasche L, Mielke S, Grigoleit UG. Einsele H, et al. Among authors: kapp m. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S51-4. doi: 10.1038/bmt.2015.96. Bone Marrow Transplant. 2015. PMID: 26039208 Review.

6

Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.

Fuji S, Löffler J, Savani BN, Einsele H, Kapp M. Fuji S, et al. Among authors: kapp m. Bone Marrow Transplant. 2017 May;52(5):657-662. doi: 10.1038/bmt.2016.306. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941771 Review.

7

T-cell therapy for cytomegalovirus infection.

Mui TS, Kapp M, Einsele H, Grigoleit GU. Mui TS, et al. Among authors: kapp m. Curr Opin Organ Transplant. 2010 Dec;15(6):744-50. doi: 10.1097/MOT.0b013e32834016b9. Curr Opin Organ Transplant. 2010. PMID: 20930639 Review.

8

Adoptive immunotherapy with virus-specific T cells.

Fuji S, Kapp M, Grigoleit GU, Einsele H. Fuji S, et al. Among authors: kapp m. Best Pract Res Clin Haematol. 2011 Sep;24(3):413-9. doi: 10.1016/j.beha.2011.06.003. Best Pract Res Clin Haematol. 2011. PMID: 21925094 Review.

9

Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Semin Hematol. 2012 Jan;49(1):10-4. doi: 10.1053/j.seminhematol.2011.10.009. Semin Hematol. 2012. PMID: 22221780 Review.

10

Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Front Immunol. 2013 Oct 14;4:330. doi: 10.3389/fimmu.2013.00330. Front Immunol. 2013. PMID: 24133497 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters